Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)

Market Cap	6.30B -22.4%
Revenue (ttm)	5.73B -7.6%
Net Income	77.12M -64.5%
EPS	0.04 -66.9%
Shares Out	1.90B
PE Ratio	87.03
Forward PE	n/a
Dividend	0.06 (1.83%)
Ex-Dividend Date	Sep 26, 2025

Volume	20,264,089
Average Volume	39,052,806
Open	3.360
Previous Close	3.280
Day's Range	3.290 - 3.360
52-Week Range	3.140 - 4.310
Beta	0.29
RSI	45.40
Earnings Date	Apr 21, 2026

About SHE:002390

Guizhou Xinbang Pharmaceutical Co., Ltd. manufactures and sells traditional Chinese medicine and other pharmaceutical products in China and internationally. The company cardiovascular and cerebrovascular, digestive system, endocrine, tumors and immunomodulatory drugs, blood system drugs, rheumatism and rheumatoid arthritis, urinary system, antipyretic and analgesic, cold medicine, gynecological medications, and anti-infective drugs. It also provides medical services. The company was founded in 1995 and is headquartered in Guiyang, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 5,059
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002390

Financial Performance

In 2024, SHE:002390's revenue was 6.03 billion, a decrease of -6.63% compared to the previous year's 6.46 billion. Earnings were 101.38 million, a decrease of -64.70%.